609 related articles for article (PubMed ID: 25723170)
1. TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma.
Oshimori N; Oristian D; Fuchs E
Cell; 2015 Feb; 160(5):963-976. PubMed ID: 25723170
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
Oshimori N
Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.
Fukuchi M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
Int J Cancer; 2004 Mar; 108(6):818-24. PubMed ID: 14712482
[TBL] [Abstract][Full Text] [Related]
4. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling.
Schober M; Fuchs E
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10544-9. PubMed ID: 21670270
[TBL] [Abstract][Full Text] [Related]
5. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
[TBL] [Abstract][Full Text] [Related]
6. TGF-β inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1.
Ganapathy A; Paterson IC; Prime SS; Eveson JW; Pring M; Price N; Threadgold SP; Davies M
Cancer Lett; 2010 Dec; 298(1):107-18. PubMed ID: 20663607
[TBL] [Abstract][Full Text] [Related]
7. TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma.
Brown JA; Yonekubo Y; Hanson N; Sastre-Perona A; Basin A; Rytlewski JA; Dolgalev I; Meehan S; Tsirigos A; Beronja S; Schober M
Cell Stem Cell; 2017 Nov; 21(5):650-664.e8. PubMed ID: 29100014
[TBL] [Abstract][Full Text] [Related]
8. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
9. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K
Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656
[TBL] [Abstract][Full Text] [Related]
10. TGF-β may control the switch between tumorigenic growth and "stem cell/mesenchymal" potentially drug-resistant states.
Bordelon JR; Grichnik JM
Dermatol Ther; 2015; 28(3):177-8. PubMed ID: 25649199
[No Abstract] [Full Text] [Related]
11. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
[TBL] [Abstract][Full Text] [Related]
12. Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant.
Bordignon P; Bottoni G; Xu X; Popescu AS; Truan Z; Guenova E; Kofler L; Jafari P; Ostano P; Röcken M; Neel V; Dotto GP
Cell Rep; 2019 Aug; 28(9):2358-2372.e6. PubMed ID: 31461652
[TBL] [Abstract][Full Text] [Related]
13. Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression.
Taniguchi S; Elhance A; Van Duzer A; Kumar S; Leitenberger JJ; Oshimori N
Science; 2020 Jul; 369(6501):. PubMed ID: 32675345
[TBL] [Abstract][Full Text] [Related]
14. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
15. Glutathione content and gamma-glutamyltranspeptidase activity in squamous cell head and neck cancer xenografts.
Bier H; Bergler W; Mende S; Ganzer U
Arch Otorhinolaryngol; 1988; 245(3):166-9. PubMed ID: 2902836
[TBL] [Abstract][Full Text] [Related]
16. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
[TBL] [Abstract][Full Text] [Related]
17. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
[TBL] [Abstract][Full Text] [Related]
19. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
20. Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo.
Lotti R; Palazzo E; Petrachi T; Dallaglio K; Saltari A; Truzzi F; Quadri M; Puviani M; Maiorana A; Marconi A; Pincelli C
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
